Azitra, Inc. (AZTR)
0.7425
+0.02
(+2.40%)
USD |
NYAM |
Nov 06, 10:28
Azitra Enterprise Value : -1.923M for Nov. 5, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 05, 2026 | -1.923M |
| November 04, 2026 | -1.374M |
| November 03, 2026 | -0.9615M |
| November 02, 2026 | -1.249M |
| October 30, 2026 | -1.656M |
| October 29, 2026 | -1.729M |
| October 28, 2026 | -0.8355M |
| October 27, 2026 | 0.4699M |
| October 26, 2026 | 2.955M |
| October 23, 2026 | -1.984M |
| October 22, 2026 | -1.984M |
| October 21, 2026 | -1.984M |
| October 20, 2026 | -1.984M |
| October 19, 2026 | -1.984M |
| October 16, 2026 | -1.984M |
| October 15, 2026 | -1.984M |
| October 14, 2026 | -1.984M |
| October 13, 2026 | -1.984M |
| October 12, 2026 | 0.8093M |
| October 09, 2026 | 1.555M |
| October 08, 2026 | 1.682M |
| October 07, 2026 | 1.682M |
| October 06, 2026 | 1.561M |
| October 05, 2026 | 1.961M |
| October 02, 2026 | 1.682M |
| Date | Value |
|---|---|
| October 01, 2026 | 1.470M |
| September 30, 2026 | 2.021M |
| September 29, 2026 | 1.597M |
| September 28, 2026 | 3.955M |
| September 25, 2026 | 3.852M |
| September 24, 2026 | 3.803M |
| September 23, 2026 | 3.712M |
| September 22, 2026 | 4.021M |
| September 21, 2026 | 4.046M |
| September 18, 2026 | 4.227M |
| September 17, 2026 | 4.470M |
| September 16, 2026 | 3.524M |
| September 15, 2026 | 4.046M |
| September 14, 2026 | 4.318M |
| September 11, 2026 | 4.476M |
| September 10, 2026 | 4.597M |
| September 09, 2026 | 4.476M |
| September 08, 2026 | 4.106M |
| September 04, 2026 | 4.561M |
| September 03, 2026 | 4.591M |
| September 02, 2026 | 4.652M |
| September 01, 2026 | 4.391M |
| August 31, 2026 | 4.288M |
| August 28, 2026 | 4.403M |
| August 27, 2026 | 4.942M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Tenax Therapeutics, Inc. | -65.90M |
| Exicure, Inc. | 3.956M |
| Century Therapeutics, Inc. | 191.58M |
| Absci Corp. | 1.414B |
| Celularity, Inc. | 90.49M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.348M |
| Total Expenses (Quarterly) | 3.348M |
| EPS Diluted (Quarterly) | -1.734 |
| Earnings Yield | -1.76K% |
| Normalized Earnings Yield | -1758.75 |